Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.420
+0.060 (4.41%)
At close: Jun 27, 2025, 4:00 PM
1.390
-0.030 (-2.11%)
After-hours: Jun 27, 2025, 7:56 PM EDT
Cerus Market Cap
Cerus has a market cap or net worth of $271.45 million as of June 27, 2025. Its market cap has decreased by -16.12% in one year.
Market Cap
271.45M
Enterprise Value
289.97M
1-Year Change
-16.12%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since December 1, 1998, Cerus's market cap has increased from $155.40M to $271.45M, an increase of 74.68%. That is a compound annual growth rate of 2.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 260.00M | -9.09% |
| Dec 31, 2024 | 286.00M | -26.93% |
| Dec 29, 2023 | 391.40M | -39.56% |
| Dec 30, 2022 | 647.60M | -44.80% |
| Dec 31, 2021 | 1.17B | 1.43% |
| Dec 31, 2020 | 1.16B | 92.90% |
| Dec 31, 2019 | 599.60M | -12.84% |
| Dec 31, 2018 | 687.90M | 78.40% |
| Dec 29, 2017 | 385.60M | -14.33% |
| Dec 30, 2016 | 450.10M | -26.68% |
| Dec 31, 2015 | 613.90M | 25.70% |
| Dec 31, 2014 | 488.40M | 7.48% |
| Dec 31, 2013 | 454.40M | 159.21% |
| Dec 31, 2012 | 175.30M | 30.14% |
| Dec 30, 2011 | 134.70M | 36.89% |
| Dec 31, 2010 | 98.40M | 27.79% |
| Dec 31, 2009 | 77.00M | 237.72% |
| Dec 31, 2008 | 22.80M | -89.05% |
| Dec 31, 2007 | 208.30M | 27.79% |
| Dec 29, 2006 | 163.00M | -28.38% |
| Dec 30, 2005 | 227.60M | 247.48% |
| Dec 31, 2004 | 65.50M | -34.63% |
| Dec 31, 2003 | 100.20M | -70.69% |
| Dec 31, 2002 | 341.90M | -52.47% |
| Dec 31, 2001 | 719.30M | -31.92% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |